1. Bonavita S, Tedeschi G, Gallo A. (2013). Morphostructural MRI Abnormalities Related to Neuropsychiatric Disorders Associated to Multiple Sclerosis. Multiple Sclerosis International 2013:6 pages.
2. Sbardella E, Tona F, Petsas N, Pantano P. (2013). DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications. Multiple Sclerosis International 2013:11 pages.
3. Nogueira L, dos Santos L, Sabino P, Alvarenga R, Santos Thuler L. (2013). Factors for Lower Walking Speed in Persons with Multiple Sclerosis. Multiple Sclerosis International 2013:8 pages.
4. Baumstarck K, Boyer L, Boucekine M, Michel P, Pelletier, Auquier P. (2013). Measuring the Quality of Life in Patients with Multiple Sclerosis in Clinical Practice: A Necessary Challenge. Multiple Sclerosis International 2013:8 pages.
5. Katsavos S, Anagnostouli M. (2013). Biomarkers in Multiple Sclerosis: An Up-to-Date Overview. Multiple Sclerosis International 2013:20 pages.
6. Bragazzi N. (2013). The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review. Multiple Sclerosis International 2013:8 pages.
7. Kim W, Kim S, Huh S, Kim H. (2012). Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis International 2012:10 pages.
8. Tardif C, Bedell B, Eskildsen S, Collins D, Pike G. (2012). Quantitative Magnetic Resonance Imaging of Cortical Multiple Sclerosis Pathology. Multiple Sclerosis International 2012:13 pages.
9. Thouvenot E, Mura F, De Verdal M, Carlander B, Charif, Schneider C, Navarre S, Camu W. (2012). Ipsilateral Uveitis and Optic Neuritis in Multiple Sclerosis. Multiple Sclerosis International 2012:4 pages.
10. Flores J, Gonzalez S, Morales X, Yescas P, Ochoa A, Corona T. (2012). Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico. Multiple Sclerosis International 2012:4 pages.
